Medicus Pharma Ltd.
For the period ended Dec 31, 2025. Filed Mar 25, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 25, 2026
MDCX$1.89+0.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Financial Statements
For the years ended December 31, 2025 and 2024
(expressed in United States dollars except number of shares)
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $8,705,218 | $4,164,323 |
| Prepaid expenses and other current assets | 1,086,121 | 1,213,984 |
| Deferred financing costs | 99,305 | - |
| Total current assets | 9,890,644 | 5,378,307 |
| Operating lease right-of-use assets | 170,733 | 268,571 |
| Total assets | 10,061,377 | 5,646,878 |
| Liabilities and Shareholder's equity | ||
| Current liabilities | ||
| Accounts payable | 3,435,297 | 1,284,612 |
| Accrued expenses and other current liabilities | 995,290 | 762,835 |
| Related party payable | 116,476 | 142,459 |
| Operating lease liability, current | 145,456 | 116,323 |
| Debentures | 5,245,543 | - |
| Total current liabilities | 9,938,062 | 2,306,229 |
| Loan payable | 25,865 | - |
| Operating lease liability, non-current | 60,139 | 205,945 |
| Total liabilities | 10,024,066 | 2,512,174 |
| Commitments and contingencies (Note 13) | ||
| Shareholders' equity | ||
| Common shares, no par value; 25,176,303 and 11,816,721 shares authorized, issued and outstanding at December 31, 2025 and 2024, respectively | 57,076,175 | 30,518,195 |
| Common shares to be issued | 313,934 | - |
| Additional paid-in capital | 6,879,575 | 1,520,412 |
| Accumulated other comprehensive income | 10,880 | - |
| Accumulated deficit | (64,348,118 | (28,903,903 |
| Total shareholders' equity attributable to Medicus Pharma Ltd. | (67,554) | 3,134,704 |
| Non-controlling interests | 104,865 | - |
| Total shareholders' equity | 37,311 | 3,134,704 |
| Total liabilities and shareholders' equity | 10,061,377 | 5,646,878 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.